Selected article for: "admission day and low incidence"

Author: Heim, Markus; Lahmer, Tobias; Rasch, Sebastian; Kriescher, Silja; Berg-Johnson, Wiebke; Fuest, Kristina; Kapfer, Barbara; Schneider, Gerhard; Spinner, Christoph D.; Geisler, Fabian; Wießner, Johannes R.; Rothe, Kathrin; Feihl, Susanne; Ranft, Andreas
Title: Rapid clinical evolution for COVID-19 translates into early hospital admission and unfavourable outcome: a preliminary report
  • Cord-id: 0v7rf064
  • Document date: 2021_4_2
  • ID: 0v7rf064
    Snippet: BACKGROUND: A wide range of mortality rates has been reported in COVID-19 patients on the intensive care unit. We wanted to describe the clinical course and determine the mortality rate in our institution’s intensive care units. METHODS: To this end, we performed a retrospective cohort study of 50 COVID-19 patients admitted to the ICU at a large German tertiary university hospital. Clinical features are reported with a focus on ICU interventions, such as mechanical ventilation, prone positioni
    Document: BACKGROUND: A wide range of mortality rates has been reported in COVID-19 patients on the intensive care unit. We wanted to describe the clinical course and determine the mortality rate in our institution’s intensive care units. METHODS: To this end, we performed a retrospective cohort study of 50 COVID-19 patients admitted to the ICU at a large German tertiary university hospital. Clinical features are reported with a focus on ICU interventions, such as mechanical ventilation, prone positioning and extracorporeal organ support. Outcome is presented using a 7-point ordinal scale on day 28 and 60 following ICU admission. RESULTS: The median age was 64 years, 78% were male. LDH and D-Dimers were elevated, and patients were low on Vitamin D. ARDS incidence was 75%, and 43/50 patients needed invasive ventilation. 22/50 patients intermittently needed prone positioning, and 7/50 required ECMO. The interval from onset of the first symptoms to admission to the hospital and to the ICU was shorter in non-survivors than in survivors. By day 60 after ICU admission, 52% of the patients had been discharged. 60-day mortality rate was 32%; 37% for ventilated patients, and 42% for those requiring both: ventilation and renal replacement therapy. CONCLUSIONS: Early deterioration might be seen as a warning signal for unfavourable outcome. Lung-protective ventilation including prone positioning remain the mainstay of the treatment.

    Search related documents:
    Co phrase search for related documents
    • activity limitation and long medium: 1
    • activity limitation and long medium term: 1
    • acute ards respiratory distress syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and long medium: 1, 2
    • acute ards respiratory distress syndrome and long medium term: 1
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • admission day and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • admission day and low molecular weight: 1, 2, 3, 4, 5, 6, 7
    • admission day and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • long medium and low molecular weight: 1
    • long medium and low molecular weight heparin: 1
    • long medium term and low molecular weight: 1
    • long medium term and low molecular weight heparin: 1
    • lopinavir ritonavir and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lopinavir ritonavir and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7